Role of acyl CoA synthetase 5 (ACSL5) in systemic metabolism was studied in an ACSL5 deficient mouse.
ACSL5 deficiency reduced total ACSL activity in liver, intestine, and brown adipose tissue.
ACSL5 deficient mice had increased hepatic and circulating FGF21 expression and energy expenditure.
ACSL5 deficient mice demonstrated delayed triglyceride absorption.